New cancer clinical trial: 177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer

Published on: August 27, 2018 at 12:00PM
Condition:   Thyroid Cancer, Medullary
Interventions:   Drug: 177Lu-PP-F11N;   Drug: Sacuitril
Sponsors:   University Hospital, Basel, Switzerland;   Krebsforschung Schweiz, Bern, Switzerland;   Center for Proton Therapy, Paul Scherrer Institute, Villigen,Switzerland;   University Hospital, Zürich;   University Hospital Freiburg
Not yet recruiting
https://ift.tt/2wjpFuo